Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)

BMJ Open
Jøran HjelmesæthCecilia Karlsson

Abstract

Roux-en-Y gastric bypass (GBP) is associated with changes in cardiometabolic risk factors and bioavailability of drugs, but whether these changes are induced by calorie restriction, the weight loss or surgery per se, remains uncertain. The COCKTAIL study was designed to disentangle the short-term (6 weeks) metabolic and pharmacokinetic effects of GBP and a very low energy diet (VLED) by inducing a similar weight loss in the two groups. This open, non-randomised, three-armed, single-centre study is performed at a tertiary care centre in Norway. It aims to compare the short-term (6 weeks) and long-term (2 years) effects of GBP and VLED on, first, bioavailability and pharmacokinetics (24 hours) of probe drugs and biomarkers and, second, their effects on metabolism, cardiometabolic risk factors and biomarkers. The primary outcomes will be measured as changes in: (1) all six probe drugs by absolute bioavailability area under the curve (AUCoral/AUCiv) of midazolam (CYP3A4 probe), systemic exposure (AUCoral) of digoxin and rosuvastatin and drug:metabolite ratios for omeprazole, losartan and caffeine, levels of endogenous CYP3A biomarkers and genotypic variation, changes in the expression and activity data of the drug-metabolising, dru...Continue Reading

Methods Mentioned

BETA
biopsies
pharmacotherapy
gastric bypass
biopsies were
biopsy
ELISA

Clinical Trials Mentioned

NCT02386917

Software Mentioned

SurveyXact
IWQOL
OWLQOL
ApnelaLink
ApneaLink
lite

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
Paulo PereiraJean Marc Chevalier
Canadian Journal of Physiology and Pharmacology
P B Karch, J R Beaton
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
Luke M Funk, Guilherme M Campos
© 2022 Meta ULC. All rights reserved